MediPharm Labs Corp. (LABS.TO)
- Previous Close
0.0800 - Open
0.0800 - Bid 0.0750 x --
- Ask 0.0800 x --
- Day's Range
0.0750 - 0.0800 - 52 Week Range
0.0600 - 0.1000 - Volume
45,405 - Avg. Volume
173,673 - Market Cap (intraday)
32.038M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Nov 12, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
www.medipharmlabs.com127
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News
View MorePerformance Overview
Trailing total returns as of 2026-08-31, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreStatistics
View MoreValuation Measures
Market Cap
34.17M
Enterprise Value
24.75M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
0.96
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.00%
Return on Assets (ttm)
-5.17%
Return on Equity (ttm)
-13.22%
Revenue (ttm)
41.46M
Net Income Avi to Common (ttm)
-4.97M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
10.42M
Total Debt/Equity (mrq)
1.19%
Levered Free Cash Flow (ttm)
2.06M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.

